By an age of 60 years, 55% of LMNA mutation carriers die of cardiovascular death or receive a heart transplant, compared with 11% of patients with idiopathic cardiomyopathy without LMNA mutation [74]. This evidence concerns the gene LMNA and idiopathic cardiomyopathy.